172 related articles for article (PubMed ID: 15781836)
1. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
Sato S; Mizuno Y; Hattori N
Neurology; 2005 Mar; 64(6):1081-3. PubMed ID: 15781836
[TBL] [Abstract][Full Text] [Related]
2. Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease.
Hirayama M; Nakamura T; Watanabe H; Uchida K; Hama T; Hara T; Niimi Y; Ito M; Ohno K; Sobue G
Parkinsonism Relat Disord; 2011 Jan; 17(1):46-9. PubMed ID: 21106430
[TBL] [Abstract][Full Text] [Related]
3. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
4. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
[TBL] [Abstract][Full Text] [Related]
5. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients.
Yano T; Shoji F; Baba H; Koga T; Shiraishi T; Orita H; Kohno H
Lung Cancer; 2009 Jan; 63(1):111-4. PubMed ID: 18676055
[TBL] [Abstract][Full Text] [Related]
6. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
[TBL] [Abstract][Full Text] [Related]
8. Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients.
Sawamoto Y; Sugano N; Tanaka H; Ito K
Oral Microbiol Immunol; 2005 Aug; 20(4):216-20. PubMed ID: 15943765
[TBL] [Abstract][Full Text] [Related]
9. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.
Kikuchi A; Takeda A; Onodera H; Kimpara T; Hisanaga K; Sato N; Nunomura A; Castellani RJ; Perry G; Smith MA; Itoyama Y
Neurobiol Dis; 2002 Mar; 9(2):244-8. PubMed ID: 11895375
[TBL] [Abstract][Full Text] [Related]
10. Oxidative DNA damage estimated by urinary 8-hydroxydeoxyguanosine and indoor air pollution among non-smoking office employees.
Lu CY; Ma YC; Lin JM; Chuang CY; Sung FC
Environ Res; 2007 Mar; 103(3):331-7. PubMed ID: 17034784
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of oxidative DNA damage in children with brain damage using 8-hydroxydeoxyguanosine levels.
Fukuda M; Yamauchi H; Yamamoto H; Aminaka M; Murakami H; Kamiyama N; Miyamoto Y; Koitabashi Y
Brain Dev; 2008 Feb; 30(2):131-6. PubMed ID: 17766071
[TBL] [Abstract][Full Text] [Related]
13. Neopterin, a marker of immune response, and 8-hydroxy-2'-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine.
Svoboda P; Ko SH; Cho B; Yoo SH; Choi SW; Ye SK; Kasai H; Chung MH
Anal Biochem; 2008 Dec; 383(2):236-42. PubMed ID: 18822267
[TBL] [Abstract][Full Text] [Related]
14. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson's disease.
Bolner A; Pilleri M; De Riva V; Nordera GP
Clin Lab; 2011; 57(11-12):859-66. PubMed ID: 22239015
[TBL] [Abstract][Full Text] [Related]
15. Increased 8-OHdG levels in the urine, serum, and substantia nigra of hemiparkinsonian rats.
Yasuhara T; Hara K; Sethi KD; Morgan JC; Borlongan CV
Brain Res; 2007 Feb; 1133(1):49-52. PubMed ID: 17188662
[TBL] [Abstract][Full Text] [Related]
16. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.
Seet RC; Lee CY; Lim EC; Tan JJ; Quek AM; Chong WL; Looi WF; Huang SH; Wang H; Chan YH; Halliwell B
Free Radic Biol Med; 2010 Feb; 48(4):560-6. PubMed ID: 19969070
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Tanaka F; Sobue G
Muscle Nerve; 2012 Nov; 46(5):692-7. PubMed ID: 22941760
[TBL] [Abstract][Full Text] [Related]
18. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults.
Xu Y; Wang Y; Zheng Q; Li X; Li B; Jin Y; Sun X; Sun G
Toxicol Appl Pharmacol; 2008 Oct; 232(1):142-9. PubMed ID: 18640141
[TBL] [Abstract][Full Text] [Related]
19. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases.
Gmitterová K; Heinemann U; Gawinecka J; Varges D; Ciesielczyk B; Valkovic P; Benetin J; Zerr I
Neurodegener Dis; 2009; 6(5-6):263-9. PubMed ID: 19955696
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress as a biomarker of respiratory disturbance in patients with severe motor and intellectual disabilities.
Tanuma N; Miyata R; Hayashi M; Uchiyama A; Kurata K
Brain Dev; 2008 Jun; 30(6):402-9. PubMed ID: 18280073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
